Skip to main content

Heart and Vessels

Ausgabe 5/2021

Inhalt (19 Artikel)

Original Article

Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: a mechanistic insight

Yuichi Saito, Naoto Mori, Takayo Murase, Takashi Nakamura, Seigo Akari, Kan Saito, Takaaki Matsuoka, Kazuya Tateishi, Tadayuki Kadohira, Hideki Kitahara, Yoshihide Fujimoto, Yoshio Kobayashi

Original Article

Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization

Masashi Yokoi, Tsuyoshi Ito, Hiroshi Fujita, Tomonori Sugiura, Yoshihiro Seo, Nobuyuki Ohte

Original Article

Subjects with coronary artery disease and reduced ejection fraction have longer (GT)n repeats in the heme-oxygenase 1 gene promoter

Kae-Woei Liang, Wen-Jane Lee, Wen-Lieng Lee, Jen-Pey Wu, I-Te Lee, Jun-Sing Wang, Wayne H.-H. Sheu

Open Access Original Article

Usefulness of dual-axis rotational coronary angiography in primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction

Hideaki Suwa, Yota Koyabu, Taichi Adachi, Akira Kawai, Kazuhiko Kotani, Shigeru Toyoda, Teruo Inoue, Toru Kato

Original Article

Three-dimensional optical coherence tomography versus intravascular ultrasound in percutaneous coronary intervention for the left main coronary artery

Katsuya Miura, Takeshi Tada, Takenobu Shimada, Masanobu Ohya, Ryosuke Murai, Shunsuke Kubo, Hiroyuki Tanaka, Yasushi Fuku, Tsuyoshi Goto, Kazushige Kadota

Original Article

Functional assessment of intermediate coronary artery stenosis with 4-Fr catheters

Kazutaka Nogi, Tsunenari Soeda, Masahiko Hara, Hajime Iwama, Nozomi Toyokawa, Satoshi Sakai, Hiroki Yano, Atsushi Iwai, Yukihiro Hashimoto, Hajime Fujimoto, Megumi Suzuki, Takehito Nakai, Naofumi Doi, Yoshihiko Saito

Original Article

Drug-coated stent implantation vs. bypass surgery for in-stent occlusion after femoropopliteal stenting

Yusuke Tomoi, Yoshimitsu Soga, Jin Okazaki, Osamu Iida, Tatsuya Shiraki, Seiichi Hiramori, Kenji Ando

Original Article

Association between ambulance use and hospitalization costs among heart failure patients

Hiroki Yasui, Nobuaki Michihata, Hiroki Matsui, Kiyohide Fushimi, Satoru Iwase, Kazuhiro Yoshiuchi, Yasushi Sakata, Hideo Yasunaga

Original Article

Cardiac rehabilitation program improves exercise capacity in heart transplantation recipients regardless of marginal donor factors

Kazufumi Kitagaki, Rei Ono, Yukihiro Shimada, Hidetoshi Yanagi, Harumi Konishi, Michio Nakanishi

Original Article

Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation

Hiroshi Hayashi, Yu-ki Iwasaki, Toshiki Arai, Rei Mimuro, Masato Hachisuka, Yujin Maru, Yuhi Fujimoto, Eiichiro Oka, Kanako Hagiwara, Yoichi Imori, Teppei Yamamoto, Hiroshige Murata, Kenji Yodogawa, Hitoshi Takano, Wataru Shimizu

Original Article

Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure

Keisuke Suzuki, Koji Miyamoto, Nobuhiko Ueda, Kenzaburo Nakajima, Tsukasa Kamakura, Mitsuru Wada, Kenichiro Yamagata, Kohei Ishibashi, Yuko Inoue, Takashi Noda, Satoshi Nagase, Takeshi Aiba, Tomoyuki Yambe, Takashi Kakuta, Naoki Tadokoro, Satsuki Fukushima, Tomoyuki Fujita, Kengo Kusano

Original Article

Serum human epididymis protein 4 levels in the prediction of the recurrence of atrial fibrillation after catheter ablation

Zhi-Jie Mao, Ya Lin, Xiao-Kang Hu, Yi-He Chen, Wei-jian Huang, Zhou-Qing Huang

Original Article

Predictors of neo-aortic valve regurgitation in the long term after arterial switch operation

Takuma Takada, Seiji Asagai, Masaki Sato, Gen Harada, Eriko Shimada, Mikiko Ishido, Tokuko Shinohara, Kei Inai, Nobuhisa Hagiwara

Original Article

Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder

Rie Nakayama, Yoichi Takaya, Teiji Akagi, Nobuhisa Watanabe, Takashi Miki, Koji Nakagawa, Norihisa Toh, Hiroshi Ito

Original Article

Late recovery of the cardiopulmonary exercise capacity after transcatheter amplatzer device closures for atrial septal defects in adults

Shigeki Yoshiba, Takuro Kojima, Takayuki Oyanagi, Koichi Toda, Yousuke Osada, Shota Muraji, Tomohiko Imamura, Shintaro Nakano, Shigeru Makita, Toshiki Kobayashi, Naokata Sumitomo

Original Article

Efficacy and safety of tolvaptan after pediatric congenital heart disease surgery

Takuro Kojima, Azusa Kanai, Shigeki Yoshiba, Toshiki Kobayashi, Naokata Sumitomo

Original Article

Differences in aggressive treatments during the actively dying phase in patients with cancer and heart disease: an exploratory study using the sampling dataset of the National Database of Health Insurance Claims

Atsushi Mizuno, Mitsunori Miyashita, Sachiko Ohde, Osamu Takahashi, Sayoko Yamauchi, Hitonari Nakazawa, Nobuyuki Komiyama

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.